Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Knight Therapeutics Inc. T.GUD

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic

Knight Therapeutics Inc, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.
Price: $9.04 | Change: $-0.12 | %Change: -1.31%
Volume: 540,921 | Day High/Low: 9.29/8.99 | 52 Week High/Low: 10.00/3.51
View modes: 
0 stars

Bought this stock because of John Goodman

Sometimes we buy stock because of the technical trends , there are time we bought because of fundamentals or future discount in earning..My sole reason when i bought this stock is Jonathan Goodman..  rate and reply
0 stars

RE:RE:Price Target

You are paying for the expertise of management.  The case for this stock to move higher is that Goodman has done this before.  He knows how to do it and proven his worth.  That is worth something.  He...read more
0 stars

Goodman mention in Antibe Therapeutics Q3 Report

Antibe Therapeutics also announced that Jonathan Ross Goodman has resigned from the Company’s Board of Directors, effective today. Mr. Goodman has been a Director since June 2013. Samira Sakhia will...read more
0 stars

RE:Price Target

My take for this stock is very close to Checkmate. In addition as a long term holder I am prepared to withstand any volatility that this stock may exhibite along the way of growth. No matter what this...read more
5 stars

RE:RE:Price Target

Agreed...targets can only be set with good data.  Right now, we have no real data, just hopes and dreams.   Jonathan can set expectations better than we can...but...even he will need to deploy more...read more
0 stars

RE:Price Target

No one has a 3 yr target. If they do they are clueless. You buy GUD for management. You and I cannot build a pharmaceutical company. The management of Paladin have shown they can So you buy today for...read more
0 stars

Price Target

Hey folks, I'm a relatively new shareholder to this stock. Does anybody have a target price for 1-3 years, either from research or through other mediums or expertise? From what I see, it is going...read more
0 stars

Received confirmation on NeurAxon...

Knight has global rights to NeurAxon...which is great considering the potential size of the market. Knight will look at commercializing within the said "Territory."  The territory refers to Canada...read more
0 stars

good dip in many non resources names today

they've all enjoyed good runs lately, well deserved pause until the next leg up due to positive news....it is Friday too. cheers, dave.  rate and reply
5 stars

RE:Someone finally decided to take profits...

You got your answer. Usually hangs around the 20 day average. 8.85-9.00 was where the buying kicked in with good selling at 10.00 into volume. Like you say, good chance to add a few as this moves over...read more
0 stars

lowriskinvestor

What I meant was does not refer to delivering FDA voucher on a regular basis  rate and reply
0 stars

lowriskinvestor

Do you have access to some privelaged information? Because Knight' vision statement does refer to deleivering FDA vouchers on a regular basis it is explicit as Knight Therapeutics Inc, is a specialty...read more
3 stars

reference to FDA voucher

I was referring to the "possibility" of a new FDA voucher in the works ...not the one sold to Gilead in Nov 2014  rate and reply
0 stars

where's the news???

expecting news in short order. deals must me underway...they've already shown the deals exist. Goodman said they just need to turn the taps on...and...here we go. Bring it on! Trying to get...read more
0 stars

RE:RE:RE:Price Drop

You mean this one that they sold in November?  The only one they owned that I am aware of. Knight Sells Priority Review Voucher to Gilead MONTREAL, QUEBEC--(Marketwired – Nov. 19, 2014...read more
0 stars

RE:RE:RE:Price Drop

The Priority Review voucher was sold to Gilead for $125 million back in November, not sure when the deal closed though.  rate and reply
0 stars

RE:RE:Price Drop

The FDA voucher that they are selling  rate and reply
0 stars

RE:Price Drop

What voucher are you talking about?  rate and reply
5 stars

RE:Price Drop

Peaked at $10 today, an important psychological figure as well.   I wouldn't mind a nice healthy pullback, gives those who missed the boat a chance to buy and current holders to buy more at cheaper...read more
1 star

Price Drop

The selling this AM is healthy after such a rapid run-up.  The drop no doubt tripped stop-loss selling.  The upward momentum of the stock for the past 60 days may be reflecting Q4 results (due mid...read more